These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 24204834
1. Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice. Kwak N, Choi SM, Lee J, Park YS, Lee CH, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ. PLoS One; 2013; 8(10):e77456. PubMed ID: 24204834 [Abstract] [Full Text] [Related]
2. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Kay AW, González Fernández L, Takwoingi Y, Eisenhut M, Detjen AK, Steingart KR, Mandalakas AM. Cochrane Database Syst Rev; 2020 Aug 27; 8(8):CD013359. PubMed ID: 32853411 [Abstract] [Full Text] [Related]
3. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand. Kawkitinarong K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, Ubolyam S, Sophonphan J, Avihingsanon A, Ruxrungtham K. Clin Infect Dis; 2017 May 15; 64(suppl_2):S171-S178. PubMed ID: 28475796 [Abstract] [Full Text] [Related]
4. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania. Pimkina E, Zablockis R, Nikolayevskyy V, Danila E, Davidaviciene E. Respir Med; 2015 Nov 15; 109(11):1484-9. PubMed ID: 26403251 [Abstract] [Full Text] [Related]
5. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W. PLoS Med; 2011 Jul 15; 8(7):e1001061. PubMed ID: 21814495 [Abstract] [Full Text] [Related]
6. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF. Ullah I, Javaid A, Masud H, Ali M, Basit A, Ahmad W, Younis F, Yasmin R, Khan A, Jabbar A, Husain M, Butt ZA. J Med Microbiol; 2017 Apr 15; 66(4):412-418. PubMed ID: 28425873 [Abstract] [Full Text] [Related]
7. Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis. Bai W, Liu L, Wu L, Chen S, Wu S, Wang Z, Xu K, Chi Q, Pan Y, Xu X. J Clin Lab Anal; 2022 Jan 15; 36(1):e24154. PubMed ID: 34850984 [Abstract] [Full Text] [Related]
9. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study. Wang P, Gu J, Yang J, Yang C, Wu X, Yu F, Fan L. Ann Palliat Med; 2020 Mar 15; 9(2):239-246. PubMed ID: 32233619 [Abstract] [Full Text] [Related]
19. Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance. Allahyartorkaman M, Mirsaeidi M, Hamzehloo G, Amini S, Zakiloo M, Nasiri MJ. Sci Rep; 2019 Dec 06; 9(1):18515. PubMed ID: 31811239 [Abstract] [Full Text] [Related]